feed,title,long_url,short_url
Benzinga,"Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027",https://benzinga.com/pressreleases/21/02/n19844983/halozyme-therapeutics-inc-announces-pricing-of-private-offering-of-700-million-of-convertible-seni,
